XRAY

Over the past six months, Dentsply Sirona's stock price declined, with a 1-year change of -29.51% as of September 17, 2026, reaching a new 52-week low of $9.36 on September 18, 2026. The company reported Q4 2025 earnings on February 26, 2026, Q1 2026 earnings on May 5, 2026, and Q2 2026 earnings on August 6, 2026. For Q2 2026, revenue of $898 million slightly beat estimates but sales declined 4.1% year-over-year, and adjusted EPS remained flat at $0.52, leading to an 8.0% stock decline the next day. An Annual General Meeting was held on June 2, 2026. Management highlighted a restructuring program targeting approximately $120 million in annual cost savings, which will be directed towards digital dentistry and R&D investments. Analyst sentiment is mixed, leaning towards "Hold," with a consensus price target of $13.31 as of September 18, 2026, with some brokerages adjusting targets both lower and higher. In May 2026, Dentsply Sirona announced an expanded partnership with Nashville Dental, Inc. to strengthen its U.S. distribution footprint for digital dentistry solutions.